COVID-19: Sensor rapidly detects severity and immunity
Source: Caltech

COVID-19: Sensor rapidly detects severity and immunity

Researchers at the California Institute of Technology (Caltech) have developed a low-cost multiplex test that can rapidly provide three different types of data on COVID-19.

One feature of the COVID-19 virus that makes it so difficult to contain is that it can be easily spread to others by a person who has yet to show any signs of infection. The carrier of the virus might feel perfectly well and go about their daily business—taking the virus with them to work, to the home of a family member, or to public gatherings.

A crucial part of the global effort to stem the spread of the pandemic, therefore, is the development of tests that can rapidly identify infections in people who are not yet symptomatic.

Now, Caltech researchers have developed a new type of multiplexed test (a test that combines multiple kinds of data) with a low-cost sensor that may enable the at-home diagnosis of a COVID infection through rapid analysis of small volumes of saliva or blood, without the involvement of a medical professional, in less than 10 minutes.

Photo
When attached to supporting electronics, the sensor can wirelessly transmit data to the user's cell phone through Bluetooth.
Source: Caltech

The research was conducted in the lab of Wei Gao, assistant professor in the Andrew and Peggy Cherng department of medical engineering. Previously, Gao and his team have developed wireless sensors that can monitor conditions such as gout, as well as stress levels, through the detection of extremely low levels of specific compounds in blood, saliva, or sweat.

Gao's sensors are made of graphene, a sheet-like form of carbon. A plastic sheet etched with a laser generates a 3D graphene structure with tiny pores. Those pores create a large amount of surface area on the sensor, which makes it sensitive enough to detect, with high accuracy, compounds that are only present in very small amounts. In this sensor, the graphene structures are coupled with antibodies, immune system molecules that are sensitive to specific proteins, like those on the surface of a COVID virus, for example.

Previous versions of the sensor were impregnated with antibodies for the hormone cortisol, which is associated with stress, and uric acid, which at high concentrations causes gout. The new version of the sensor, which Gao has named SARS-CoV-2 RapidPlex, contains antibodies and proteins that allow it to detect the presence of the virus itself; antibodies created by the body to fight the virus; and chemical markers of inflammation, which indicate the severity of the COVID-19 infection.

Photo
An artist's rendering showing how the sensor contains areas that each detect a different indicator of a COVID-19 infection.
Source: Caltech

"This is the only telemedicine platform I've seen that can give information about the infection in three types of data with a single sensor," Gao says. "In as little as a few minutes, we can simultaneously check these levels, so we get a full picture about the infection, including early infection, immunity, and severity."

Established COVID-testing technologies usually take hours or even days to produce results. Those technologies also require expensive, complicated equipment, whereas Gao's system is simple and compact.

So far, the device has been tested only in the lab with a small number of blood and saliva samples obtained for medical research purposes from individuals who have tested positive or negative for COVID-19. Though preliminary results indicate that the sensor is highly accurate, a larger-scale test with real-world patients rather than laboratory samples must be performed, Gao cautions, to definitively determine its accuracy.

With the pilot study now completed, Gao next plans to test how long the sensors last with regular use, and to begin testing them with hospitalized COVID-19 patients. Following in-hospital testing, he would like to study the suitability of the tests for in-home use. Following testing, the device will need to receive regulatory approval before it is available for widespread use at home. "Our ultimate aim really is home use," he says. "In the following year, we plan to mail them to high-risk individuals for at-home testing. And in the future, this platform could be modified for other types of infectious disease testing at home."

Subscribe to our newsletter

Related articles

Smart ring detects COVID-19 early

Smart ring detects COVID-19 early

According to new research, the Oura smart ring is indeed suitable for detecting COVID-19 infection up to three days before symptoms appear.

Medical technology 2020 – a review

Medical technology 2020 – a review

Covid-19 gave many of these predictions for 2020 an entirely new spin: while some of the hyped trends turned out to play only bit-parts others became box-office hits in the new normal.

Mobile disinfection robots for medical environments

Mobile disinfection robots for medical environments

The following seven robotic systems are either currently being deployed or developed for the fight against the coronavirus.

Paper-based sensor rapidly detects COVID-19

Paper-based sensor rapidly detects COVID-19

Researchers have developed a rapid, ultrasensitive test using a paper-based electrochemical sensor that can detect the presence of the virus in less than five minutes.

Quantum nanodiamonds help detect disease earlier

Quantum nanodiamonds help detect disease earlier

The quantum sensing abilities of nanodiamonds can be used to improve the sensitivity of paper-based diagnostic tests, potentially allowing for earlier detection of diseases such as HIV.

COVID-19: AI system monitores vital health signs

COVID-19: AI system monitores vital health signs

A key symptom of COVID-19 – oxygen saturation – is now being estimated remotely from a camera, thanks to research from University of South Australia (UniSA).

Sorting out viruses with machine learning

Sorting out viruses with machine learning

Scientists develop a label-free method for identifying respiratory viruses based on changes in electrical current when they pass through silicon nanopores.

Holographic imaging to detect viruses

Holographic imaging to detect viruses

A new approach using holographic imaging to detect both viruses and antibodies has the potential to aid in medical diagnoses and, specifically, those related to the COVID-19 pandemic.

UV light disinfection could prevent virus spread

UV light disinfection could prevent virus spread

A device capable of automatically disinfecting common surfaces could be a vital tool in virus and disease mitigation during and after the COVID-19 pandemic.

Popular articles